Cargando…

A systematic review on the economic burden of interstitial lung disease and the cost-effectiveness of current therapies

BACKGROUND: The economic burden of interstitial lung disease (ILD) is unknown, limiting informed resource allocation and planning. We sought to conduct the first systematic review on the direct, indirect, and overall costs associated with ILD and to evaluate the cost-effectiveness of current therapi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wong, Alyson W., Koo, John, Ryerson, Christopher J., Sadatsafavi, Mohsen, Chen, Wenjia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9020025/ https://www.ncbi.nlm.nih.gov/pubmed/35443657 http://dx.doi.org/10.1186/s12890-022-01922-2

Ejemplares similares

Progression of fibrosing interstitial lung disease
por: Wong, Alyson W., et al.
Publicado: (2020)

A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease
por: Wong, Alyson W., et al.
Publicado: (2020)

Treatment of rheumatoid arthritis-associated interstitial lung disease in a multi-center registry cohort
por: Marcoux, Veronica, et al.
Publicado: (2023)

Validation and minimum important difference of the UCSD Shortness of Breath Questionnaire in fibrotic interstitial lung disease
por: Chen, Tao, et al.
Publicado: (2021)

Making Sense of Bronchoalveolar Lavage Lymphocytosis in Fibrotic Interstitial Lung Disease
por: Ryerson, Christopher J.
Publicado: (2020)

Cost-Effectiveness of Bronchial Thermoplasty, Omalizumab, and Standard Therapy for Moderate-to-Severe Allergic Asthma
por: Zafari, Zafar, et al.
Publicado: (2016)

Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis
por: Lee, Cathryn T., et al.
Publicado: (2022)

Practical Considerations for the Diagnosis and Treatment of Fibrotic Interstitial Lung Disease During the Coronavirus Disease 2019 Pandemic
por: Wong, Alyson W., et al.
Publicado: (2020)

The opportunities and challenges of social media in interstitial lung disease: a viewpoint
por: Grewal, Japnam S., et al.
Publicado: (2021)

Cardiopulmonary Exercise Testing in Patients With Interstitial Lung Disease
por: Molgat-Seon, Yannick, et al.
Publicado: (2020)

Endobronchial Optical Coherence Tomography for the Diagnosis of Fibrotic Interstitial Lung Disease: A Light at the End of the Tunnel?
por: Marinescu, Daniel-Costin, et al.
Publicado: (2021)

The Fatigue Severity Scale in Interstitial Lung Disease: An Energizing Endpoint
por: Wong, Alyson W., et al.
Publicado: (2023)

Burden of non-adherence to latent tuberculosis infection drug therapy and the potential cost-effectiveness of adherence interventions in Canada: a simulation study
por: Patel, Anik R, et al.
Publicado: (2017)

Unclassifiable interstitial lung disease: an unresolved diagnostic dilemma
por: Leung, Stefanie C, et al.
Publicado: (2015)

Supplemental oxygen and dypsnoea in interstitial lung disease: absence of evidence is not evidence of absence
por: Schaeffer, Michele R., et al.
Publicado: (2017)

The Genomic Classifier and Our Quest for Diagnostic Certainty in Interstitial Lung Disease
por: Wong, Alyson W., et al.
Publicado: (2022)

The Long-Term Burden of COPD Exacerbations During Maintenance Therapy and Lung Function Decline
por: Kerkhof, Marjan, et al.
Publicado: (2020)

Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis
por: Joy, Greta M., et al.
Publicado: (2023)

Burden of Disease and Productivity Loss in the European Economic Area in Patients Affected by Fibrosing Interstitial Lung Disease
por: Løkke, Anders, et al.
Publicado: (2023)

Economic burden of interstitial lung disease in a commercially insured population with Sjögren syndrome in the United States
por: Lee, Tsung-Ying, et al.
Publicado: (2022)

Epidemiology, costs, and the economic burden of fibromyalgia
por: Spaeth, Michael
Publicado: (2009)

Economic Cost and Burden of Dengue in the Philippines
por: Edillo, Frances E., et al.
Publicado: (2015)

The economics of precision health: preventing air pollution-induced exacerbation in asthma
por: Mohammadi, Tima, et al.
Publicado: (2021)

Economic burden of smoking: a systematic review of direct and indirect costs
por: Rezaei, Satar, et al.
Publicado: (2016)

The economic burden of stroke: a systematic review of cost of illness studies
por: Strilciuc, Stefan, et al.
Publicado: (2021)

The prevalence and burden of interstitial lung diseases in the USA
por: Jeganathan, Niranjan, et al.
Publicado: (2021)

The Burden of Progressive-Fibrosing Interstitial Lung Diseases
por: Cottin, Vincent, et al.
Publicado: (2022)

Reply: Quantitative Computed Tomography in Systemic Sclerosis–Interstitial Lung Disease: Are We Ready to Go beyond Standard Assessment?
por: Castillo Saldana, Daniela, et al.
Publicado: (2021)

A contemporary practical approach to the multidisciplinary management of unclassifiable interstitial lung disease
por: Ryerson, Christopher J., et al.
Publicado: (2021)

Walking the path of treatable traits in interstitial lung diseases
por: Amati, Francesco, et al.
Publicado: (2023)

Dehydroepiandrosterone in fibrotic interstitial lung disease: a translational study
por: Guler, Sabina A., et al.
Publicado: (2022)

Economic burden of maternal morbidity – A systematic review of cost-of-illness studies
por: Moran, Patrick S., et al.
Publicado: (2020)

Gender modifies the effect of body mass index on lung function decline in mild-to-moderate COPD patients: a pooled analysis
por: Chen, Wenjia, et al.
Publicado: (2021)

Current estimates of the economic burden of blindness and visual impairment in India: A cost of illness study
por: Mannava, Sunny, et al.
Publicado: (2022)

Societal economic burden of multiple sclerosis and cost-effectiveness of disease-modifying therapies
por: Simoens, Steven
Publicado: (2022)

Research Burden of Interstitial Lung Diseases in Turkey – RBILD
por: Aycicek, Olcay, et al.
Publicado: (2022)

Burden of illness in progressive fibrosing interstitial lung disease
por: Singer, David, et al.
Publicado: (2022)

Current Developments in Interstitial Lung Disease
por: Mori, Shunsuke, et al.
Publicado: (2016)

Demographic and clinical predictors of progression and mortality in connective tissue disease-associated interstitial lung disease: a retrospective cohort study
por: Chan, Chrystal, et al.
Publicado: (2019)

The Economic Burden of Small Cell Lung Cancer: A Systematic Review of the Literature
por: Enstone, Ashley, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2rfdrhl46qv61efq0a9blngnid